Disregulated Expression of the Th2 Cytokine Gene in Patients with Intraoral Squamous Cell Carcinoma

References

• Banat G. A., Christ O., Cochlovius B., Pralle H. B., Zoller M. Tumour‐induced suppression of immune response and its correction. Cancer Immunol. Immunother. 2001; 49: 573–586
   PubMed Web of Science ®Google Scholar
• Barth R. J., Jr., Camp B. J., Martuscello T., Dain B. J., Memoli V. J. The cytokine microenvironment of human colon carcinoma lymphocyte expression of tumor necrosis factor‐γ and interleukin‐4 predicts improved survival. Cancer 1996; 78: 1168–1177
   PubMed Web of Science ®Google Scholar
• Chen L., Linsley P. S., Hellstrom K. E. Costimulation of T‐cells for tumour immunity. Immunol. Today 1993; 14: 483–486
   PubMedGoogle Scholar
• Coffman R. L., Varkila K., Scott P., Chatelain R. Role of cytokines in the differentiation of CD4+ T‐cell sub‐sets in vivo. Immunol. Rev. 1991; 123: 189–197
   PubMed Web of Science ®Google Scholar
• Das S. N., Khanna N. N., Khanna S. Delayed hypersensitivity in patients with carcinoma of the oral cavity. Ann. Acad. Med. Singap. 1983; 12: 416–419
   PubMedGoogle Scholar
• Das S. N., Khanna N. N., Khanna S. An observation of in vivo and in vitro parameters of cellular immune competence in oral cancer and their correlation with tumour load and prognosis. Cancer Investig. 1986; 4: 207–218
   PubMed Web of Science ®Google Scholar
• Del Prete G. F., De Carli M., Ricci M., Romagnani S. Helper activity for immunoglobulin synthesis of T helper type I (Th1) and Th2 human T‐cell clones: the help of Th1 clones is limited by their cytotoxic capacity. J. Exp. Med. 1991; 174: 809–813
   PubMed Web of Science ®Google Scholar
• Ehlers S., Smith K. A. Differentiation of T‐cell lymphokine gene expression: the in vitro acquisition of T‐cell memory. J. Exp. Med. 1991; 173: 25–36
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Finch F. W. Antiproliferative effects of IFN‐γ in immune regulation I. IFN‐γ inhibits the proliferation of Th2 but not Th1 murine helper T‐lymphocyte clones. J. Immunol. 1988; 140: 4245–4252
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Lancki D. W., Stack R., Fitch F. W. Anergy of the Th0 helper T‐lymphocytes induces downregulation of Th1 characteristics and a transition to a Th‐2 like phenotype. J. Exp. Med. 1993; 179: 481–486
   Google Scholar
• Goto S., Sato M., Kaneko R., Itoh M., Sato S., Takeuchi S. Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol. Immunother. 1999; 48: 435–442
   PubMed Web of Science ®Google Scholar
• Gratas C., Tohma Y., Barnas C., Taniere P., Hainaut P., Ohgaki H. Upregulation of Fas (APO‐1/CD95) ligand and downregulation of Fas expression in human oesophageal cancer. Cancer Res. 1998; 58: 2057–2062
   PubMed Web of Science ®Google Scholar
• Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L. E. Melanoma cell expression of Fas (Apo‐1/CD95) ligand; implications for tumour immune escape. Science 1996; 274: 1363–1366
   PubMed Web of Science ®Google Scholar
• Halak B. K., Maguire H. C., Lattime E. C. Tumour induced interleukin 10 inhibits type I immune responses directed at a tumour antigen as well as a non tumour antigen present at the tumour site. Cancer Res. 1999; 59: 911–917
   PubMed Web of Science ®Google Scholar
• Heinzel F. P., Sadick M. D., Holaday B. J., Coffman R., Locksley R. M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T‐cell subsets. J. Exp. Med. 1989; 169: 59–72
   PubMed Web of Science ®Google Scholar
• Hsieh C. S., Heimberger A. B., Gold J. S., O'Garra A., Murphy K. Differential regulation of T‐helper phenotype development by IL‐4 and IL‐10 in an αβ–transgenic system. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 6065–6069
   PubMed Web of Science ®Google Scholar
• Jung T., Lack G., Schauer U., Uberuck W., Renz H., Gelfand E. W., Rieger C. H. Allergens, IgE1 mediators inflammatory mechanisms. Decreased frequency of interferon‐γ and interleukin‐2 producing cells in patients with atopic diseases measured at the single cell level. J. Allergy Clin. Immunol. 1995; 96: 515–527
   PubMedGoogle Scholar
• Kelso A., Groves P., Troutt A. B., Francis K. Evidence for the stochastic acquisition of cytokine profile by CD4+ T‐cells activated in a T‐helper type 2‐like response in vivo. Eur. J. Immunol. 1995; 25: 1168–1175
   PubMed Web of Science ®Google Scholar
• Khanna N. N., Das S. N., Khanna S. Serum immunoglobulins in squamous cell carcinoma of the oral cavity. J. Surg. Oncol. 1982; 20: 46–48
   Google Scholar
• Knerer B., Hulla W., Martinek H., Formanek M., Temmel A., Kornfehl J. IL‐1 and TNF‐α but not IL‐2 expression is found in squamous cell carcinomas of the head and neck by RT‐PCR. Acta Oto‐laryngol. 1996; 116: 132–136
   PubMed Web of Science ®Google Scholar
• Lucey D. R., Clerici M., Shearer G. M. Type I and type II cytokine disregulation in human infections, neoplastic and inflammatory diseases. Clin. Microbiol. Rev. 1996; 9: 532–562
   PubMed Web of Science ®Google Scholar
• Macatonia S. E., Hsieh C. S., Murphy K., O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4+ T‐cells from αβ‐TCR transgenic mice: IL‐12 substitution for macrophages to stimulate IFN‐γ production in IFN‐γ dependent. Int. Immunol. 1993; 5: 1119–1128
   PubMed Web of Science ®Google Scholar
• Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M. P., Rugiu F. S., et al. Reciprocal regulatory effects of IFN‐γ and IL‐4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 1992; 148: 2142–2147
   PubMed Web of Science ®Google Scholar
• Meyaard L., Hovenkamp E., Keet I. P.M., Hooibrink B., Jong I. H., Otto S. A., Meidema F. Single cell analysis of IL‐4 and IFN‐γ production by T‐cells from HIV‐infected individuals. J. Immunol. 1996; 157: 2712–2718
   PubMedGoogle Scholar
• Misra N., Murtaza A., Walker B., Shankar Narayan N. P., Misra R. S., Ramesh V., et al. Cytokine profile of circulating T‐cells of leprosy patients reflect both indiscriminate and polarized T‐helper subsets: T‐helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 1995; 86: 97–103
   PubMedGoogle Scholar
• Mosmann T. R., Chervinski H., Bond M. W., Geidlin M. A., Coffman R. L. Two types of murine helper T‐cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Schumacher J. H., Street N. F., Budd R., O'Gara A., Fong T. A. Diversity of cytokine synthesis and function of mouse CD4+ T‐cells. Immunol. Rev. 1991; 123: 209–229
   PubMed Web of Science ®Google Scholar
• Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol. 1987; 155: 335–350
   PubMed Web of Science ®Google Scholar
• O'Gara A., Murphy K. Role of cytokines in determining T‐lymphocyte functions. Curr. Opin. Immunol. 1994; 6: 458–466
   Google Scholar
• Pellegrini P., Barghella A. M., Del Beato T., Cicia S., Adorono D., Casciani C. U. Disregulation in Th1 and Th2 subsets of CD4+ T‐cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol. Immunother. 1996; 42: 1–8
   PubMed Web of Science ®Google Scholar
• Powrie F., Coffman R. Interleukin‐4 and Interleukin‐10 synergize to inhibit cell mediated immunity in vivo. Eur. J. Immunol. 1993; 23: 2223–2229
   PubMedGoogle Scholar
• Rabinowich H., Suminami Y., Reichert T. E., Crowley‐Nowick P., Bell M., Edwards R. Expression of cytokine genes or proteins and signalling molecules in lymphocytes associated with human ovarian carcinoma. Int. J. Cancer. 1996; 68: 276–284
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A. Immunotherapy and gene therapy of cancer. Cancer Res. 1991; 51: 5074s–5079s
   PubMed Web of Science ®Google Scholar
• Roussel E., Cingras M. C., Grimm E. A., Bruner J. M., Moser R. P. Predominance of intratumoral immune response in fresh tumour‐infiltrating lymphocytes from human gliomas. Clin. Exp. Immunol. 1996; 105: 344–352
   PubMedGoogle Scholar
• Seder R. A., Paul W. E. Acquisition of lymphokine producing phenotype by CD4+ T‐cells. Annu. Rev. Immunol. 1994; 12: 635–673
   PubMed Web of Science ®Google Scholar
• Tamada K., Harada M., Abe K., Li T., Nomoto K. Immunosuppressive activity of cloned natural killer (NK 1.1+) T‐cell established from murine tumour infiltrating lymphocytes. J. Immunol. 1997; 158: 4846–4854
   Google Scholar
• Tinhofer I., Marschitz I., Kos M., Henn T., Egle E., Villunger A., Greil R. Differential sensitivity of CD4+ and CD8+ T‐lymphocytes to the killing efficacy of Fas (Apo1/CD95) ligand+ tumour cells in B chronic lymphocytic leukemia. Blood 1998; 91: 4273–4284
   PubMed Web of Science ®Google Scholar
• Walker B. R., Butler R., Colston M. J. Role of Th1 lymphocytes in the development of protective immunity against Mycobacterium leprae. Analysis of lymphocyte function by polymerase chain reaction detection of cytokine messenger RNA. J. Immunol. 1992; 148: 1885–1889
   Google Scholar
• Wang M. B., Lichtensteim A., Mickel R. A. Hierarchical immunosuppression of regional lymphnodes in patients with head and neck squamous cell carcinoma. Otolaryngol. Head Neck Surg. 1991; 105: 517–527
   Google Scholar
• Wang Q., Redovan C., Tubbs R., Olencki T., Klein E., Kudoh S. Selective cytokine gene expression in renal cell carcinoma tumour cells and tumour infittrating lymphocytes. Int. J. Cancer. 1995; 61: 780–785
   PubMed Web of Science ®Google Scholar
• Woods K. V., El‐Naggar A., Clayman G. L., Grimm E. A. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res. 1998; 58: 3132–3141
   PubMed Web of Science ®Google Scholar
• Zaks T. Z., Chappell D. B., Rosenberg S. A., Restifo N. P. CD95‐mediated suicide of tumour‐reactive T‐cells following activation by specific tumour selective rescue by caspase inhibition. J. Immunol. 1999; 162: 3273–3279
   PubMed Web of Science ®Google Scholar